Home / Recalls / Actavis Inc / D-1386-2014

D-1386-2014 Class II Terminated

Recalled by Actavis Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
June 25, 2014
Initiation Date
May 16, 2014
Termination Date
February 23, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6913 packages

Product Description

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

Reason for Recall

Subpotent Drug.

Distribution Pattern

U.S. Nationwide

Code Information

Lot #: 3100135, Expiry: 05/2014

Other recalls by Actavis Inc

  • D-0514-2017 Class III — Levofloxacin Ophthalmic Solution, 0.5%, Sterile, packaged in 5mL bottles, Rx On (February 7, 2017)
  • D-0476-2017 Class II — Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactu (January 30, 2017)
  • D-0439-2017 Class III — Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, (January 12, 2017)
  • D-1472-2016 Class III — Hydrocortisone and acetic acid otic solution, Rx only, 10 mL bottle, Distributed (August 2, 2016)
  • D-1471-2016 Class III — Acetasol HC (hydrocortisone and acetic acid otic solution USP) , Rx Only, 10 mL (August 2, 2016)
  • D-1448-2016 Class II — Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, R (July 11, 2016)
  • D-1457-2016 Class II — Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufacture (June 30, 2016)
  • D-1148-2015 Class III — Lutera (0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol tablets USP), 28 day (June 4, 2015)
  • D-0406-2015 Class II — Vancomycin Hydrochloride Capsules, USP, 250 mg, 2 x 10 count blister pack, Rx On (February 12, 2015)
  • D-0396-2015 Class II — Vancomycin Hydrochloride Capsules, USP, 125 mg, 2 x 10 count blister pack, Rx On (February 12, 2015)